Gulf International Bank (Uk) LTD Alnylam Pharmaceuticals, Inc. Transaction History
Gulf International Bank (Uk) LTD
- $3.96 Billion
- Q4 2024
A detailed history of Gulf International Bank (Uk) LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 9,754 shares of ALNY stock, worth $2.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,754
Previous 9,853
1.0%
Holding current value
$2.5 Million
Previous $2.71 Million
15.28%
% of portfolio
0.06%
Previous 0.07%
Shares
18 transactions
Others Institutions Holding ALNY
# of Institutions
669Shares Held
112MCall Options Held
866KPut Options Held
799K-
Capital World Investors Los Angeles, CA16.6MShares$4.26 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.27 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.45 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.79 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.12 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...